Literature DB >> 23117845

Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI.

Lars Stegger1, Petros Martirosian, Nina Schwenzer, Sotirios Bisdas, Armin Kolb, Christina Pfannenberg, Claus D Claussen, Bernd Pichler, Fritz Schick, Andreas Boss.   

Abstract

BACKGROUND: Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) with simultaneous data acquisition promises a comprehensive evaluation of cerebral pathophysiology on a molecular, anatomical, and functional level. Considering the necessary changes to the MR scanner design the feasibility of arterial spin labeling (ASL) is unclear.
PURPOSE: To evaluate whether cerebral blood flow imaging with ASL is feasible using a prototype PET/MRI device.
MATERIAL AND METHODS: ASL imaging of the brain with Flow-sensitive Alternating Inversion Recovery (FAIR) spin preparation and true fast imaging in steady precession (TrueFISP) data readout was performed in eight healthy volunteers sequentially on a prototype PET/MRI and a stand-alone MR scanner with 128 × 128 and 192 × 192 matrix sizes. Cerebral blood flow values for gray matter, signal-to-noise and contrast-to-noise ratios, and relative signal change were compared. Additionally, the feasibility of ASL as part of a clinical hybrid PET/MRI protocol was demonstrated in five patients with intracerebral tumors.
RESULTS: Blood flow maps showed good delineation of gray and white matter with no discernible artifacts. The mean blood flow values of the eight volunteers on the PET/MR system were 51 ± 9 and 51 ± 7 mL/100 g/min for the 128 × 128 and 192 × 192 matrices (stand-alone MR, 57 ± 2 and 55 ± 5, not significant). The value for signal-to-noise (SNR) was significantly higher for the PET/MRI system using the 192 × 192 matrix size (P < 0.01), the relative signal change (δS) was significantly lower for the 192 × 192 matrix size (P = 0.02). ASL imaging as part of a clinical hybrid PET/MRI protocol could successfully be accomplished in all patients in diagnostic image quality.
CONCLUSION: ASL brain imaging is feasible with a prototype hybrid PET/MRI scanner, thus adding to the value of this novel imaging technique.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117845     DOI: 10.1258/ar.2012.120191

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  8 in total

1.  Regional correlation between resting state FDG PET and pCASL perfusion MRI.

Authors:  Yoon-Hee K Cha; Mayank A Jog; Yoon-Chung Kim; Shruthi Chakrapani; Stephen M Kraman; Danny J J Wang
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

Review 2.  PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan.

Authors:  Tomohiro Kaneta
Journal:  Jpn J Radiol       Date:  2020-02-10       Impact factor: 2.374

Review 3.  Auditory neuroimaging with fMRI and PET.

Authors:  Thomas M Talavage; Javier Gonzalez-Castillo; Sophie K Scott
Journal:  Hear Res       Date:  2013-09-27       Impact factor: 3.208

4.  Arterial Spin-Labeling Parameters Influence Signal Variability and Estimated Regional Relative Cerebral Blood Flow in Normal Aging and Mild Cognitive Impairment: FAIR versus PICORE Techniques.

Authors:  K-O Lövblad; M-L Montandon; M Viallon; C Rodriguez; S Toma; X Golay; P Giannakopoulos; S Haller
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-16       Impact factor: 3.825

5.  Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Authors:  D L Bailey; G Antoch; P Bartenstein; H Barthel; A J Beer; S Bisdas; D A Bluemke; R Boellaard; C D Claussen; C Franzius; M Hacker; H Hricak; C la Fougère; B Gückel; S G Nekolla; B J Pichler; S Purz; H H Quick; O Sabri; B Sattler; J Schäfer; H Schmidt; J van den Hoff; S Voss; W Weber; H F Wehrl; T Beyer
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

6.  Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?

Authors:  Jiahe Tian; Liping Fu; Dayi Yin; Jinming Zhang; Yingmao Chen; Ningyu An; Baixuan Xu
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 7.  Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review.

Authors:  Alessio Smeraldo; Alfonso Maria Ponsiglione; Andrea Soricelli; Paolo Antonio Netti; Enza Torino
Journal:  Int J Nanomedicine       Date:  2022-07-29

8.  Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; G Antoch; H Barthel; Z M Bhujwalla; S Biskup; S Biswal; M Bitzer; R Boellaard; R F Braren; C Brendle; K Brindle; A Chiti; C la Fougère; R Gillies; V Goh; M Goyen; M Hacker; L Heukamp; G M Knudsen; A M Krackhardt; I Law; J C Morris; K Nikolaou; J Nuyts; A A Ordonez; K Pantel; H H Quick; K Riklund; O Sabri; B Sattler; E G C Troost; M Zaiss; L Zender; Thomas Beyer
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.